Marc Klapholz

Marc Klapholz, MD, FACC, FSCAI is Professor & Chair, Department of Medicine, and Chief of Service at Rutgers - New Jersey Medical School in New Jersey. He also serves as the Director of the Heart Failure Prevention and Treatment Program. Dr. Klapholz received his medical degree from the Albert Einstein College of Medicine, Bronx, New York. He completed his residency in internal medicine, an NIH sponsored Heart Failure Research Fellowship, General Cardiology and Interventional Cardiology Fellowship at the Albert Einstein College of Medicine and Bronx Municipal Hospital Center. He is board-certified in Internal Medicine, Cardiovascular Disease, Echocardiography and Interventional Cardiology and Heart Failure & Transplant. Dr. Klapholz has been a principal investigator on over 100 clinical trials in heart failure and other cardiovascular diseases. He serves on AHA Grant Review Committees, the Heart Failure Society of America Guidelines Committee and on the Editorial Board of several journals. He has been the chairman and member of numerous Steering, Endpoint and Data Safety Monitoring Board Committees for national and international trials in heart failure. His major research interests include the evaluation of novel therapeutic agents and devices for the treatment of heart failure. He has authored and co-authored numerous articles, book chapters, monographs, and reviews in cardiovascular disease.